Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Sadia Shakoor

Biographic Data

ID1256903
NAMESadia Shakoor
GIVEN NAMESSadia
FAMILY NAMEShakoor
SIGNATURESHAKOOR S
AFFILIATIONSAga Khan University
ORCID0000-0003-1301-5239
VERIFIEDYes
TOTAL WORKS20
TOTAL CITATIONS0
WORKS AS AUTHOR8
WORKS AS EDITOR12
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2026
H-INDEX0
  • The public health utility of whole genome sequencing

    Open Access•Daisy Wang, Angeline Ferdinand et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Whole Genome Sequencing (WGS) is increasingly being used to enhance tuberculosis (TB) surveillance and management. However, evidence on how WGS shapes real-world decision-making remains limited. This study explored the utility of WGS in the context of a TB outbreak in Victoria, Australia. We conducted a case study to (1) describe a TB outbreak in Victoria using epidemiological and genomic data and (2) explore the perceived benefits and limitation…

  • Measuring vaccine effects on antibiotic use and antimicrobial resistance in low and middle-income countries

    Open Access•Chinwe Iwu-Jaja, Chidozie Declan Iwu et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Vaccines represent a critical strategy for combating antimicrobial resistance (AMR), yet methodological approaches for assessing their impact remain heterogeneous, particularly in low- and middle-income countries (LMICs) where both infectious disease and resistance burdens are highest. This scoping review systematically mapped the methodological approaches, data sources, and outcome measures used to evaluate vaccine impacts on AMR in LMICs. We se…

  • NTDscope

    Open Access•María Díaz de León Derby, Zaina L Moussa et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Accurate diagnostics are essential for disease control and elimination efforts. However, access to diagnostics for neglected tropical diseases (NTDs) is hindered by limited healthcare infrastructure in many NTD-endemic regions, as well as by reliance on time- and labor-intensive diagnostic methods, such as smear microscopy. New diagnostic tools that are portable, rapid, low-cost, and meet World Health Organization (WHO) sensitivity and specificit…

  • Not forgetting the humanitarian contexts in the fight against antimicrobial resistance

    Open Access•Pilar García-Vello, Carine Naim et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    Despite Antimicrobial Resistance (AMR) being a growing threat to global public health, there is scarce evidence from humanitarian settings. Working in fragile contexts, Médecins Sans Frontières (MSF) is well positioned to identify knowledge gaps, raise unrecognised issues, and contribute to the global AMR agenda. Based on MSF’s experience, this review intends to highlight the research priorities on AMR for the most vulnerable patients. Infection …

  • A narrative review of the pathophysiology of sepsis in sub-Saharan Africa

    Open Access•Phoebe Gruccio, William S Girard et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    Sepsis remains a significant global health threat with a disproportionate burden in low-income countries including those in sub-Saharan Africa where case fatality rates are as high as 30% to 50%. Defined as a severe systemic response to infection, sepsis leads to widespread immune dysregulation and organ dysfunction, including adrenal insufficiency. Critical illness-related corticosteroid insufficiency (CIRCI) arises from dysregulation of the hyp…

  • WHO target product profile for TB detection at peripheral settings

    Open Access•Mikashmi Kohli, Alexei Korobitsyn et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    In 2014, the World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal criteria to address high-priority TB diagnostic needs. Since then, the TB community’s needs have evolved; there has been a surge in new and innovative platforms suggesting use of alternative non-invasive specimens for TB diagnosis. This updated TPP used evidence-based modelling to guide the decision-making process for specific …

  • Barriers and facilitators to digital technology application for antimicrobial resistance surveillance

    Open Access•Ayodele Akinyele, Emmanuel Olamijuwon et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    The systematic collection, analysis, and interpretation of antimicrobial resistance (AMR) data are imperative to quantify the AMR burden, monitor and identify emerging AMR, and inform global, international, and national health strategies and guidelines. Despite ongoing global efforts to improve surveillance capacities across Nigeria and other African countries, laboratory information management systems (LIMS) that could improve data quality, and …

  • Global burden of bacterial antimicrobial resistance 1990–2021

    Open Access•Mohsen Naghavi, Stein Emil Vollset et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional publications that provided more detailed estimates for several WHO regions by country. To date, there have been no studies that produce comprehensive estimates of AMR burden across locations that encompass historical trends and future for…

  • Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention

    Open Access•Mishal Khan, Muhammad Naveed Noor et al.•ARTICLE•BMJ Global Health•2024

    INTRODUCTION: Incentive-linked prescribing, which is when healthcare providers accept incentives from pharmaceutical companies for prescribing promoted medicines, is a form of bribery that harms patients and health systems globally. We developed a novel method using data collectors posing as pharmaceutical company sales representatives to evaluate private doctors' engagement in incentive-linked prescribing and the impact of a multifaceted educati…

  • Healthcare seeking behavior and delays in case of Drug-Resistant Tuberculosis patients in Bangladesh

    Open Access•Md Zulqarnine Ibne Noman, Shariful Islam et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    The emergence of Drug-Resistant Tuberculosis (DR-TB) has become a major threat globally and Bangladesh is no exception. Delays in healthcare seeking, proper diagnosis and initiation of treatment cause continuous transmission of the resistant tubercule bacilli through the communities. This study aimed to assess the different health care-seeking behaviors and delays among DR-TB patients in Bangladesh. A prospective cross-sectional study was conduct…

  • Healthcare consumers’ perceptions of incentive-linked prescribing

    Open Access•Muhammad Naveed Noor, Haider Safdar Abbasi et al.•ARTICLE•PLOS Global Public Health•2024

    Incentive-linked prescribing (ILP) is considered a controversial practice universally. If incentivised, physicians may prioritise meeting pharmaceutical sales targets through prescriptions, rather than considering patients’ health and wellbeing. Despite the potential harms of ILP to patients and important stakeholders in the healthcare system, healthcare consumers (HCCs) which include patients and the general public often have far less awareness …

  • Socioecological factors linked with pharmaceutical incentive-driven prescribing in Pakistan

    Open Access•Muhammad Naveed Noor, Afifah Rahman-Shepherd et al.•ARTICLE•BMJ Global Health•2023

    Pharmaceutical marketing through financial incentivisation to general practitioners (GPs) is a poorly studied health system problem in Pakistan. Pharmaceutical incentivisation is seen to be distorting GPs prescribing behaviour that can compromise the health and well-being of patients. We draw on a conceptual framework outlined in the ecological system theory to identify multiple factors linked with pharmaceutical incentivisation to GPs in Pakista…

  • Prognostic accuracy of biomarkers of immune and endothelial activation in Mozambican children hospitalized with pneumonia

    Open Access•Núria Balanza, Clara Erice et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Pneumonia is a leading cause of child mortality. However, currently we lack simple, objective, and accurate risk-stratification tools for pediatric pneumonia. Here we test the hypothesis that measuring biomarkers of immune and endothelial activation in children with pneumonia may facilitate the identification of those at risk of death. We recruited children

  • Incentivisation practices and their influence on physicians’ prescriptions

    Open Access•Mishal Khan, Afifah Rahman-Shepherd et al.•ARTICLE•PLOS Global Public Health•2023

    Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …

  • Knowledge and attitudes toward complete diagnostic autopsy and minimally invasive autopsy

    Open Access•Ngan Ta Thi Dieu, Nhung Doan Phuong et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Knowing the cause of death (CoD) plays an important role in developing strategies and interventions to prevent early mortality. In Vietnam, the CoD of the majority of patients who acquired infectious diseases remains unknown. While there are challenges that hinder the use of complete diagnostic autopsy (CDA) in practice, minimally invasive autopsy (MIA) might be a promising alternative to establish CoD in Vietnam. The current study aims to explor…

  • Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

    Open Access•Emily Lai-Ho MacLean, Paolo Miotto et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deployable in peripheral settings. In 2014, World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal cri…

  • Application of diagnostic network optimization in Kenya and Nepal to design integrated, sustainable and efficient bacteriology and antimicrobial resistance surveillance networks

    Open Access•Marie Brunetti, Amit Singh et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries, which experience the highest burden of AMR. Critical to combatting AMR is ensuring there are effective, accessible diagnostic networks in place to diagnose, monitor and prevent AMR, but many low- and middle-income countries lack such networks. Consequently, there is substantial need for approaches that can inform the design of…

  • The healthcare field as a marketplace

    Muhammad Naveed Noor, Marco Liverani et al.•ARTICLE•Health Sociology Review•2023•References: 39

    Incentivisation of general practitioners (GPs) by pharmaceutical companies is thought to affect prescribing practices, often not in patients' interest. Using a Bourdieusian lens, we examine the socially structured conditions that underpin exchanges between pharmaceutical companies and GPs in Pakistan. The analysis of qualitative interviews with 28 GPs and 13 pharmaceutical sales representatives (PSRs) shows that GPs, through prescribing medicines…

  • Open Online Courses for Strengthening Laboratory-Based Detection of Antimicrobial Resistance in Pakistan

    Open Access•Noureen Saeed, Mohammad Zeeshan et al.•ARTICLE•Frontiers in Public Health•2022

    Introduction Quality-assured antimicrobial susceptibility testing (AST) depends upon the knowledge and skills of laboratory staff. In many low- and middle-income countries (LMICs), including Pakistan, such types of knowledge and skills are limited. Therefore, the objective of this study was to use openaccess online courses to improve the knowledge of laboratory staff involved in the detection and reporting of antimicrobial resistance (AMR). Metho…

  • Validation of community health worker identification of maternal puerperal sepsis using a clinical diagnostic algorithm in Bangladesh and Pakistan

    Open Access•Amnesty LeFevre, Amnesty E LeFevre et al.•ARTICLE•Journal of Global Health•2021

    BACKGROUND: Puerperal sepsis (PP sepsis) is a leading cause of maternal mortality globally. The majority of maternal sepsis cases and deaths occur at home and remain undiagnosed and under-reported. In this paper, we present findings from a nested case-control study in Bangladesh and Pakistan which sought to assess the validity of community health worker (CHW) identification of PP sepsis using a clinical diagnostic algorithm with physician assessm…

No prominent works on this page.

  • Validation of community health worker identification of maternal puerperal sepsis using a clinical diagnostic algorithm in Bangladesh and Pakistan

    Open Access•Amnesty LeFevre, Amnesty E LeFevre et al.•ARTICLE•Journal of Global Health•2021

    BACKGROUND: Puerperal sepsis (PP sepsis) is a leading cause of maternal mortality globally. The majority of maternal sepsis cases and deaths occur at home and remain undiagnosed and under-reported. In this paper, we present findings from a nested case-control study in Bangladesh and Pakistan which sought to assess the validity of community health worker (CHW) identification of PP sepsis using a clinical diagnostic algorithm with physician assessm…

  • Open Online Courses for Strengthening Laboratory-Based Detection of Antimicrobial Resistance in Pakistan

    Open Access•Noureen Saeed, Mohammad Zeeshan et al.•ARTICLE•Frontiers in Public Health•2022

    Introduction Quality-assured antimicrobial susceptibility testing (AST) depends upon the knowledge and skills of laboratory staff. In many low- and middle-income countries (LMICs), including Pakistan, such types of knowledge and skills are limited. Therefore, the objective of this study was to use openaccess online courses to improve the knowledge of laboratory staff involved in the detection and reporting of antimicrobial resistance (AMR). Metho…

  • Socioecological factors linked with pharmaceutical incentive-driven prescribing in Pakistan

    Open Access•Muhammad Naveed Noor, Afifah Rahman-Shepherd et al.•ARTICLE•BMJ Global Health•2023

    Pharmaceutical marketing through financial incentivisation to general practitioners (GPs) is a poorly studied health system problem in Pakistan. Pharmaceutical incentivisation is seen to be distorting GPs prescribing behaviour that can compromise the health and well-being of patients. We draw on a conceptual framework outlined in the ecological system theory to identify multiple factors linked with pharmaceutical incentivisation to GPs in Pakista…

  • Prognostic accuracy of biomarkers of immune and endothelial activation in Mozambican children hospitalized with pneumonia

    Open Access•Núria Balanza, Clara Erice et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Pneumonia is a leading cause of child mortality. However, currently we lack simple, objective, and accurate risk-stratification tools for pediatric pneumonia. Here we test the hypothesis that measuring biomarkers of immune and endothelial activation in children with pneumonia may facilitate the identification of those at risk of death. We recruited children

  • Incentivisation practices and their influence on physicians’ prescriptions

    Open Access•Mishal Khan, Afifah Rahman-Shepherd et al.•ARTICLE•PLOS Global Public Health•2023

    Focus on profit-generating enterprise in healthcare can create conflicts of interest that adversely impact prescribing and pricing of medicines. Although a global challenge, addressing the impacts on quality of care is particularly difficult in countries where the pharmaceutical industry and physician lobby is strong relative to regulatory institutions. Our study characterises the range of incentives exchanged between the pharmaceutical industry …

  • Knowledge and attitudes toward complete diagnostic autopsy and minimally invasive autopsy

    Open Access•Ngan Ta Thi Dieu, Nhung Doan Phuong et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Knowing the cause of death (CoD) plays an important role in developing strategies and interventions to prevent early mortality. In Vietnam, the CoD of the majority of patients who acquired infectious diseases remains unknown. While there are challenges that hinder the use of complete diagnostic autopsy (CDA) in practice, minimally invasive autopsy (MIA) might be a promising alternative to establish CoD in Vietnam. The current study aims to explor…

  • Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

    Open Access•Emily Lai-Ho MacLean, Paolo Miotto et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deployable in peripheral settings. In 2014, World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal cri…

  • Application of diagnostic network optimization in Kenya and Nepal to design integrated, sustainable and efficient bacteriology and antimicrobial resistance surveillance networks

    Open Access•Marie Brunetti, Amit Singh et al.•EDITOR•ARTICLE•PLOS Global Public Health•2023

    Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries, which experience the highest burden of AMR. Critical to combatting AMR is ensuring there are effective, accessible diagnostic networks in place to diagnose, monitor and prevent AMR, but many low- and middle-income countries lack such networks. Consequently, there is substantial need for approaches that can inform the design of…

  • The healthcare field as a marketplace

    Muhammad Naveed Noor, Marco Liverani et al.•ARTICLE•Health Sociology Review•2023•References: 39

    Incentivisation of general practitioners (GPs) by pharmaceutical companies is thought to affect prescribing practices, often not in patients' interest. Using a Bourdieusian lens, we examine the socially structured conditions that underpin exchanges between pharmaceutical companies and GPs in Pakistan. The analysis of qualitative interviews with 28 GPs and 13 pharmaceutical sales representatives (PSRs) shows that GPs, through prescribing medicines…

  • Global burden of bacterial antimicrobial resistance 1990–2021

    Open Access•Mohsen Naghavi, Stein Emil Vollset et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional publications that provided more detailed estimates for several WHO regions by country. To date, there have been no studies that produce comprehensive estimates of AMR burden across locations that encompass historical trends and future for…

  • Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention

    Open Access•Mishal Khan, Muhammad Naveed Noor et al.•ARTICLE•BMJ Global Health•2024

    INTRODUCTION: Incentive-linked prescribing, which is when healthcare providers accept incentives from pharmaceutical companies for prescribing promoted medicines, is a form of bribery that harms patients and health systems globally. We developed a novel method using data collectors posing as pharmaceutical company sales representatives to evaluate private doctors' engagement in incentive-linked prescribing and the impact of a multifaceted educati…

  • Healthcare seeking behavior and delays in case of Drug-Resistant Tuberculosis patients in Bangladesh

    Open Access•Md Zulqarnine Ibne Noman, Shariful Islam et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    The emergence of Drug-Resistant Tuberculosis (DR-TB) has become a major threat globally and Bangladesh is no exception. Delays in healthcare seeking, proper diagnosis and initiation of treatment cause continuous transmission of the resistant tubercule bacilli through the communities. This study aimed to assess the different health care-seeking behaviors and delays among DR-TB patients in Bangladesh. A prospective cross-sectional study was conduct…

  • Healthcare consumers’ perceptions of incentive-linked prescribing

    Open Access•Muhammad Naveed Noor, Haider Safdar Abbasi et al.•ARTICLE•PLOS Global Public Health•2024

    Incentive-linked prescribing (ILP) is considered a controversial practice universally. If incentivised, physicians may prioritise meeting pharmaceutical sales targets through prescriptions, rather than considering patients’ health and wellbeing. Despite the potential harms of ILP to patients and important stakeholders in the healthcare system, healthcare consumers (HCCs) which include patients and the general public often have far less awareness …

  • Not forgetting the humanitarian contexts in the fight against antimicrobial resistance

    Open Access•Pilar García-Vello, Carine Naim et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    Despite Antimicrobial Resistance (AMR) being a growing threat to global public health, there is scarce evidence from humanitarian settings. Working in fragile contexts, Médecins Sans Frontières (MSF) is well positioned to identify knowledge gaps, raise unrecognised issues, and contribute to the global AMR agenda. Based on MSF’s experience, this review intends to highlight the research priorities on AMR for the most vulnerable patients. Infection …

  • A narrative review of the pathophysiology of sepsis in sub-Saharan Africa

    Open Access•Phoebe Gruccio, William S Girard et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    Sepsis remains a significant global health threat with a disproportionate burden in low-income countries including those in sub-Saharan Africa where case fatality rates are as high as 30% to 50%. Defined as a severe systemic response to infection, sepsis leads to widespread immune dysregulation and organ dysfunction, including adrenal insufficiency. Critical illness-related corticosteroid insufficiency (CIRCI) arises from dysregulation of the hyp…

  • WHO target product profile for TB detection at peripheral settings

    Open Access•Mikashmi Kohli, Alexei Korobitsyn et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    In 2014, the World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal criteria to address high-priority TB diagnostic needs. Since then, the TB community’s needs have evolved; there has been a surge in new and innovative platforms suggesting use of alternative non-invasive specimens for TB diagnosis. This updated TPP used evidence-based modelling to guide the decision-making process for specific …

  • Barriers and facilitators to digital technology application for antimicrobial resistance surveillance

    Open Access•Ayodele Akinyele, Emmanuel Olamijuwon et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    The systematic collection, analysis, and interpretation of antimicrobial resistance (AMR) data are imperative to quantify the AMR burden, monitor and identify emerging AMR, and inform global, international, and national health strategies and guidelines. Despite ongoing global efforts to improve surveillance capacities across Nigeria and other African countries, laboratory information management systems (LIMS) that could improve data quality, and …

  • The public health utility of whole genome sequencing

    Open Access•Daisy Wang, Angeline Ferdinand et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Whole Genome Sequencing (WGS) is increasingly being used to enhance tuberculosis (TB) surveillance and management. However, evidence on how WGS shapes real-world decision-making remains limited. This study explored the utility of WGS in the context of a TB outbreak in Victoria, Australia. We conducted a case study to (1) describe a TB outbreak in Victoria using epidemiological and genomic data and (2) explore the perceived benefits and limitation…

  • Measuring vaccine effects on antibiotic use and antimicrobial resistance in low and middle-income countries

    Open Access•Chinwe Iwu-Jaja, Chidozie Declan Iwu et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Vaccines represent a critical strategy for combating antimicrobial resistance (AMR), yet methodological approaches for assessing their impact remain heterogeneous, particularly in low- and middle-income countries (LMICs) where both infectious disease and resistance burdens are highest. This scoping review systematically mapped the methodological approaches, data sources, and outcome measures used to evaluate vaccine impacts on AMR in LMICs. We se…

  • NTDscope

    Open Access•María Díaz de León Derby, Zaina L Moussa et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Accurate diagnostics are essential for disease control and elimination efforts. However, access to diagnostics for neglected tropical diseases (NTDs) is hindered by limited healthcare infrastructure in many NTD-endemic regions, as well as by reliance on time- and labor-intensive diagnostic methods, such as smear microscopy. New diagnostic tools that are portable, rapid, low-cost, and meet World Health Organization (WHO) sensitivity and specificit…

Medicine (14 works) · Antibiotic Use and Resistance (7 works) · Business (7 works) · Nursing (6 works) · Family medicine (5 works) · Health care (5 works) · Pharmaceutical Economics and Policy (5 works) · Pharmaceutical industry and healthcare (5 works) · Political science (5 works) · Public health (5 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae